Data for serum 1,5 anhydroglucitol concentration in different populations
Marciane Welter,
Kátia C. Boritza,
Mauren I. Anghebem-Oliveira,
Railson Henneberg,
Aline B. Hauser,
Fabiane G.M. Rego,
Geraldo Picheth
Affiliations
Marciane Welter
Post Graduate Program in Pharmaceutical Sciences, Federal University of Parana, Curitiba, Parana, Brazil
Kátia C. Boritza
Post Graduate Program in Pharmaceutical Sciences, Federal University of Parana, Curitiba, Parana, Brazil
Mauren I. Anghebem-Oliveira
Department of Clinical Analysis, Federal University of Parana, Rua Prefeito Lothário Meissner, 632, 80210-170 Curitiba, Parana, Brazil
Railson Henneberg
Department of Clinical Analysis, Federal University of Parana, Rua Prefeito Lothário Meissner, 632, 80210-170 Curitiba, Parana, Brazil
Aline B. Hauser
Department of Clinical Analysis, Federal University of Parana, Rua Prefeito Lothário Meissner, 632, 80210-170 Curitiba, Parana, Brazil
Fabiane G.M. Rego
Post Graduate Program in Pharmaceutical Sciences, Federal University of Parana, Curitiba, Parana, Brazil; Department of Clinical Analysis, Federal University of Parana, Rua Prefeito Lothário Meissner, 632, 80210-170 Curitiba, Parana, Brazil; Corresponding author at: Department of Clinical Analysis, Federal University of Parana, Rua Prefeito Lothário Meissner, 632, 80210-170 Curitiba, Parana, Brazil.
Geraldo Picheth
Post Graduate Program in Pharmaceutical Sciences, Federal University of Parana, Curitiba, Parana, Brazil; Department of Clinical Analysis, Federal University of Parana, Rua Prefeito Lothário Meissner, 632, 80210-170 Curitiba, Parana, Brazil
1,5 anhydroglucitol (1,5-AG), is a nonmetabolized 1-deoxy form of glucose, originate mainly from the diet. 1,5-AG is a biomarker to detect and magnify hyperglycemic excursions (postprandial hyperglycemia) in diabetic patients. Concentrations of 1,5-AG has been applied as supporting biomarker to diagnosis of the major forms of diabetes (type 1, type 2, and gestational). The serum 1,5-AG reference interval is relevant to the appropriate clinical application of this biomarker. This article contains data regards to serum concentration of the biomarker primarily for healthy subjects, capture from the literature, in different populations. Correlation analysis between 1,5-AG and markers associated with diabetes and its complication were presented. The data was complementary to the study “Reference intervals for serum 1,5-anhydroglucitol in children, adolescents, adults, and pregnant women” (Welter et al., 2018). The data present in this article improve the comparisons for 1,5-AG in different conditions and methodologies.
